Zolertine
Zolertine
 |
| Names |
| IUPAC name
1-Phenyl-4-[2-(tetrazol-5-yl)ethyl]piperazine |
| Identifiers |
| |
4004-94-8 |
| ChemSpider |
22131 |
InChI=1S/C13H18N6/c1-2-4-12(5-3-1)19-10-8-18(9-11-19)7-6-13-14-16-17-15-13/h1-5H,6-11H2,(H,14,15,16,17)
Key: XTTHMUYLNLEJRS-UHFFFAOYSA-N InChI=1/C13H18N6/c1-2-4-12(5-3-1)19-10-8-18(9-11-19)7-6-13-14-16-17-15-13/h1-5H,6-11H2,(H,14,15,16,17)
Key: XTTHMUYLNLEJRS-UHFFFAOYAE
|
| Jmol-3D images |
Image |
| PubChem |
23669 |
C1CN(CCN1CCC2=NNN=N2)C3=CC=CC=C3
|
| Properties |
| Molecular formula |
C13H18N6 |
| Molar mass |
258.32 g·mol−1 |
Except where noted otherwise, data is given for materials in their standard state (at 25 °C (77 °F), 100 kPa) |
|
| Infobox references |
|
|
Zolertine is an alpha-adrenoceptor antagonist.[1]
References
- ↑ Ibarra, M; Hong, E; Villalobos-Molina, R (2000). "The alpha-adrenoceptor antagonist, zolertine, inhibits alpha1D- and alpha1A-adrenoceptor-mediated vasoconstriction in vitro". Journal of autonomic pharmacology 20 (3): 139–45. PMID 11193002.